|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,190 GBX | +1.35% |
|
-0.86% | +15.00% |
| 02/06 | Astra's Enhertu breast cancer trial shows 'unprecedented' results | RE |
| 02/06 | Astra's Enhertu delays breast cancer in patients with low HER2 levels | RE |
(Reuters) - AstraZeneca is planning to build a $1.5 billion manufacturing facility in Singapore in an effort to enhance its antibody drug conjugates (ADCs) portfolio, the drugmaker said on Monday.
(Reporting by Radhika Anilkumar in Bengaluru; Editing by Sherry Jacob-Phillips)
| 1st Jan change | Capi. | |
|---|---|---|
| +15.00% | 240B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
ASTRAZENECA PLC 
